28.82
1.55%
+0.44
アフターアワーズ:
28.80
-0.02
-0.07%
Pfizer Inc. (PFE) 最新ニュース
Pfizer: Best Trading Momentum Since 2021 And 6% Yield
Seeking Alpha
3 No-Brainer Stocks to Buy With $500 Right Now
The Motley Fool
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Benzinga
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
The Motley Fool
Is This a Setback for Moderna?
The Motley Fool
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks Investment Research
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks Investment Research
How Viking Therapeutics Stock Could 30x
The Motley Fool
The Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet
Zacks Investment Research
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
The Motley Fool
Earn $1000 Every Month From These 3 Stocks
The Motley Fool
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
Benzinga
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks Investment Research
2 Beaten-Down Stocks to Buy and Hold for 10 Years
The Motley Fool
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Benzinga
How To Build An 8% Yielding SWAN Portfolio With 10 Blue Chips
Seeking Alpha
2 No-Brainer Dividend Stocks to Buy in May
The Motley Fool
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
The Motley Fool
Pfizer: A 6% Yield And At 10-Year Lows
Seeking Alpha
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
The Motley Fool
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'
Benzinga
Pfizer: Solid Earnings, But We're Not Out Of The Woods Yet
Seeking Alpha
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Zacks Investment Research
Pfizer: Ignore The Dead Cat Bounce
Seeking Alpha
3 No-Brainer Stocks to Buy in May
The Motley Fool
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
The Motley Fool
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
The Motley Fool
SCHD: A Must-Have In Every Dividend Portfolio
Seeking Alpha
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks Investment Research
Here's Why Pfizer (PFE) is a Strong Momentum Stock
Zacks Investment Research
Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'
Benzinga
My Top 5 Favorite High-Yield Dividend Stocks to Buy in May
The Motley Fool
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
The Motley Fool
Company News for May 2, 2024
Zacks Investment Research
Pfizer (PFE) Q1 2024 Earnings Call Transcript
The Motley Fool
Why Pfizer Stock Blasted More Than 6% Higher Today
The Motley Fool
US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?
Benzinga
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks Investment Research
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks Investment Research
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks Investment Research
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings
Benzinga
Eli Lilly (LLY) Tops Q1 Earnings Estimates
Zacks Investment Research
5 Top Stocks to Buy in May
The Motley Fool
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
The Motley Fool
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead
The Motley Fool
Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1?
Seeking Alpha
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks Investment Research
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):